Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Long-tem Efficacy, Safety, and Tolerability Study of BOTOX in Patients With Chronic Migraine

Trial Profile

A Long-tem Efficacy, Safety, and Tolerability Study of BOTOX in Patients With Chronic Migraine

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Jul 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Acronyms COMPEL
  • Sponsors AbbVie; Allergan
  • Most Recent Events

    • 20 Jun 2020 Results presented at the 62nd Annual Scientific Meeting of the American Headache Society
    • 20 Jun 2020 Results of post-hoc analysis assessing proportions of chronic migraine patients reductions in headache days treated with onabotulinumtoxin A, presented at the 62nd Annual Scientific Meeting of the American Headache Society.
    • 15 Jun 2020 According to an AbbVie media release, data from this trial will be presented at the Virtual 2020 Annual Scientific Meeting of the American Headache Society.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top